165 related articles for article (PubMed ID: 38432938)
1. [Chemical Design of Radiohalogenated Agents Using Neopentyl Structure].
Uehara T
Yakugaku Zasshi; 2024; 144(3):285-290. PubMed ID: 38432938
[TBL] [Abstract][Full Text] [Related]
2. Neopentyl Glycol as a Scaffold to Provide Radiohalogenated Theranostic Pairs of High
Suzuki H; Kaizuka Y; Tatsuta M; Tanaka H; Washiya N; Shirakami Y; Ooe K; Toyoshima A; Watabe T; Teramoto T; Sasaki I; Watanabe S; Ishioka NS; Hatazawa J; Uehara T; Arano Y
J Med Chem; 2021 Nov; 64(21):15846-15857. PubMed ID: 34708646
[TBL] [Abstract][Full Text] [Related]
3. Targeting peptides and positron emission tomography.
Lundqvist H; Tolmachev V
Biopolymers; 2002; 66(6):381-92. PubMed ID: 12658725
[TBL] [Abstract][Full Text] [Related]
4. In vivo stable
Suzuki H; Kannaka K; Hirayama M; Yamashita T; Kaizuka Y; Kobayashi R; Yasuda T; Takahashi K; Uehara T
EJNMMI Radiopharm Chem; 2024 Jun; 9(1):48. PubMed ID: 38884866
[TBL] [Abstract][Full Text] [Related]
5. Single photon emission computed tomography and positron emission tomography in cancer imaging.
Coleman RE
Cancer; 1991 Feb; 67(4 Suppl):1261-70. PubMed ID: 1991287
[TBL] [Abstract][Full Text] [Related]
6. Labeling monoclonal antibodies with halogen nuclides.
Zalutsky MR; Garg PK; Narula AS
Acta Radiol Suppl; 1990; 374():141-5. PubMed ID: 1966962
[TBL] [Abstract][Full Text] [Related]
7. Development of a PET/SPECT agent for amyloid imaging in Alzheimer's disease.
Wang Y; Klunk WE; Debnath ML; Huang GF; Holt DP; Shao L; Mathis CA
J Mol Neurosci; 2004; 24(1):55-62. PubMed ID: 15314250
[TBL] [Abstract][Full Text] [Related]
8. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
9. Strategies for the labeling of halogen-substituted peroxisome proliferator-activated receptor gamma ligands: potential positron emission tomography and single photon emission computed tomography imaging agents.
Lee BC; Lee KC; Lee H; Mach RH; Katzenellenbogen JA
Bioconjug Chem; 2007; 18(2):514-23. PubMed ID: 17315977
[TBL] [Abstract][Full Text] [Related]
10. Radiopharmaceutical chemistry with iodine-124: a non-standard radiohalogen for positron emission tomography.
Chacko AM; Divgi CR
Med Chem; 2011 Sep; 7(5):395-412. PubMed ID: 21711220
[TBL] [Abstract][Full Text] [Related]
11. 1-(
Sasaki I; Tada M; Liu Z; Tatsuta M; Okura T; Aoki M; Takahashi K; Ishioka NS; Watanabe S; Tanaka H
Org Biomol Chem; 2023 Sep; 21(36):7467-7472. PubMed ID: 37670575
[TBL] [Abstract][Full Text] [Related]
12. Effects of
Tago T; Toyohara J; Fujimaki R; Tatsuta M; Song R; Hirano K; Iwai K; Tanaka H
Nucl Med Biol; 2021; 94-95():38-45. PubMed ID: 33493787
[TBL] [Abstract][Full Text] [Related]
13. Radiohalogen-labeled imaging agents. 3. Compounds for measurement of brain blood flow by emission tomography.
Sargent T; Shulgin AT; Mathis CA
J Med Chem; 1984 Aug; 27(8):1071-7. PubMed ID: 6611416
[TBL] [Abstract][Full Text] [Related]
14. Comparative biodistribution of the radiohalogenated (Br, I and At) antibody A33. Implications for in vivo dosimetry.
Orlova A; Höglund J; Lubberink M; Lebeda O; Gedda L; Lundqvist H; Tolmachev V; Sundin A
Cancer Biother Radiopharm; 2002 Aug; 17(4):385-96. PubMed ID: 12396703
[TBL] [Abstract][Full Text] [Related]
15. The next generation of positron emission tomography radiopharmaceuticals in oncology.
Rice SL; Roney CA; Daumar P; Lewis JS
Semin Nucl Med; 2011 Jul; 41(4):265-82. PubMed ID: 21624561
[TBL] [Abstract][Full Text] [Related]
16. Advances in the Chemistry of Astatine and Implications for the Development of Radiopharmaceuticals.
Guérard F; Maingueneau C; Liu L; Eychenne R; Gestin JF; Montavon G; Galland N
Acc Chem Res; 2021 Aug; ():. PubMed ID: 34350753
[TBL] [Abstract][Full Text] [Related]
17. Scandium and terbium radionuclides for radiotheranostics: current state of development towards clinical application.
Müller C; Domnanich KA; Umbricht CA; van der Meulen NP
Br J Radiol; 2018 Nov; 91(1091):20180074. PubMed ID: 29658792
[TBL] [Abstract][Full Text] [Related]
18. Single photon emission computed tomography/positron emission tomography imaging and targeted radionuclide therapy of melanoma: new multimodal fluorinated and iodinated radiotracers.
Maisonial A; Kuhnast B; Papon J; Boisgard R; Bayle M; Vidal A; Auzeloux P; Rbah L; Bonnet-Duquennoy M; Miot-Noirault E; Galmier MJ; Borel M; Askienazy S; Dollé F; Tavitian B; Madelmont JC; Moins N; Chezal JM
J Med Chem; 2011 Apr; 54(8):2745-66. PubMed ID: 21417462
[TBL] [Abstract][Full Text] [Related]
19. Preliminary Characterization and In Vivo Studies of Structurally Identical (18)F- and (125)I-Labeled Benzyloxybenzenes for PET/SPECT Imaging of β-Amyloid Plaques.
Yang Y; Zhang X; Cui M; Zhang J; Guo Z; Li Y; Zhang X; Dai J; Liu B
Sci Rep; 2015 Jul; 5():12084. PubMed ID: 26170205
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]